2/2
09:31 am
cgem
Rating for CGEM
Medium
Report
Rating for CGEM
2/2
09:31 am
cgem
Rating for CGEM
Medium
Report
Rating for CGEM
2/2
04:49 am
cgem
Cullinan Therapeutics initiated with a Buy at Guggenheim
Medium
Report
Cullinan Therapeutics initiated with a Buy at Guggenheim
2/2
04:49 am
cgem
Cullinan Therapeutics initiated with a Buy at Guggenheim
Medium
Report
Cullinan Therapeutics initiated with a Buy at Guggenheim
2/1
08:16 pm
cgem
Cullinan Therapeutics (NASDAQ:CGEM) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
Medium
Report
Cullinan Therapeutics (NASDAQ:CGEM) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
2/1
08:16 pm
cgem
Cullinan Therapeutics (NASDAQ:CGEM) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
Medium
Report
Cullinan Therapeutics (NASDAQ:CGEM) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
2/1
07:19 pm
cgem
Cullinan Therapeutics initiated with a Buy at Guggenheim
Medium
Report
Cullinan Therapeutics initiated with a Buy at Guggenheim
2/1
07:19 pm
cgem
Cullinan Therapeutics initiated with a Buy at Guggenheim
Medium
Report
Cullinan Therapeutics initiated with a Buy at Guggenheim
1/8
10:57 am
cgem
Cullinan Therapeutics (NASDAQ:CGEM) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Cullinan Therapeutics (NASDAQ:CGEM) had its "buy" rating reaffirmed by analysts at HC Wainwright.
1/8
08:02 am
cgem
Cullinan Therapeutics (NASDAQ:CGEM) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Cullinan Therapeutics (NASDAQ:CGEM) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
1/8
08:02 am
cgem
Cullinan Therapeutics (NASDAQ:CGEM) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Cullinan Therapeutics (NASDAQ:CGEM) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
12/9
08:16 am
cgem
Rating for CGEM
Low
Report
Rating for CGEM
12/9
08:16 am
cgem
Rating for CGEM
Low
Report
Rating for CGEM
11/24
12:25 pm
cgem
Rating for CGEM
Medium
Report
Rating for CGEM
11/24
12:08 pm
cgem
Cullinan Therapeutics (NASDAQ:CGEM) had its "buy" rating reaffirmed by analysts at BTIG Research.
High
Report
Cullinan Therapeutics (NASDAQ:CGEM) had its "buy" rating reaffirmed by analysts at BTIG Research.
11/20
11:08 pm
cgem
Cullinan Therapeutics (NASDAQ:CGEM) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $25.00 price target on the stock.
Medium
Report
Cullinan Therapeutics (NASDAQ:CGEM) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $25.00 price target on the stock.
11/20
11:08 pm
cgem
Cullinan Therapeutics (NASDAQ:CGEM) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $25.00 price target on the stock.
Medium
Report
Cullinan Therapeutics (NASDAQ:CGEM) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $25.00 price target on the stock.